All treatments
Treatment
Oxaliplatin Eugia 5 mg/ml concentraat voor oplossing voor infusie clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
Neo-adjuvant intraperitoneal chemotherapy (irinotecan) and systemic chemotherapy (mFOLFOX4-bevacizumab) prior to CRS-HIPEC for patients with isolated resectable colorectal peritoneal metastases: a multicentre, phase II trial (INTERACT-PLUS)
This study looks at new ways to treat bowel cancer that has spread to the lining of the tummy. It tests a combination of medicines given before surgery to see if it helps patients. The goal is to improve treatment for this type of cancer.
For: Patients with colorectal peritoneal metastases with a PCI-score of 1-20Netherlands - AuthorisedPhase II and Phase III (Integrated)
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for resectable colorectal peritoneal metastases: a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6).
This study compares two ways to treat bowel cancer that has spread to the lining of the tummy. It looks at whether adding chemotherapy before surgery helps people live longer compared to surgery alone. The aim is to find the best treatment plan.
For: Resectable peritoneal metastases of a colorectal originBelgium · Netherlands